Trademark247.com - Trademark Search Results

Showing 1-20 of 121 results

Mark Name	Mark Description
PROLINK Owned by: DISCOVERX CORP Filed on: 01-03-2007 Status: Abandoned-Failure to Resp...	Chemical Reagents for non-medical purposes, namely, recombinant reagents	View Details Monitor Mark Create New Watchlist
GONAL F Owned by: ARES TRADING S.... Filed on: 05-14-1998 Status: Abandoned-No Statement of...	PHARMACEUTICAL PREPARATION, NAMELY, RECOMBINANT FOLLICLE STIMULATING HORMONE FOR MEDICAL TREATMENT MEDICAL DEVICES, NAMELY, PEN INJECTORS AND PH	View Details Monitor Mark Create New Watchlist
GONAL F Owned by: ARES TRADING S.... Filed on: 07-15-2002 Status: Cancelled-Section 8	pharmaceuticals, namely, recombinant follicle stimulating hormone for medical treatment	View Details Monitor Mark Create New Watchlist
BETATROPIN Owned by: BIONEBRASKA, IN... Filed on: 07-03-2001 Status: Abandoned-Failure to Resp...	recombinant Glycogen-like Peptide-1 for treatment of diabetes.	View Details Monitor Mark Create New Watchlist
RSCFV Owned by: VIRIV CORP. Filed on: 05-02-2000 Status: Cancelled-Section 8	Custom manufacturing of recombinant, single-chain, phage-displayed, soluble, monoclonal, variable and antibody fragments to the order and specif	View Details Monitor Mark Create New Watchlist
PRODUCELL Owned by: THROMB-X NV Filed on: 03-19-2003 Status: Abandoned-No Statement of...	Chemical, biochemical, biological and biotechnological preparations and substances for scientific and medical research use, namely, recombinant	View Details Monitor Mark Create New Watchlist
DEFACTO Owned by: KABI PHARMACIA ... Filed on: 08-16-1993 Status: Abandoned-No Statement of...	blood products; namely, anti hemophilic factor (recombinant factor-VIII) for the treatment of hemophilia A	View Details Monitor Mark Create New Watchlist
PROCELLEX Owned by: PROTALIX LTD. Filed on: 07-11-2007 Status: Renewed	[ Bioreactor for cell culturing ] [ Chemical, biochemical, biological and biotechnological preparations and substances for scientific and medica	View Details Monitor Mark Create New Watchlist
SWIVAX Owned by: MERIAL, INC. Filed on: 11-16-2005 Status: Cancelled-Section 8	Vaccines and immunogens or antigens or vectors or recombinant vectors used to prepare vaccines, and biological immunogens or antigens for use in	View Details Monitor Mark Create New Watchlist
EPITROPIN Owned by: CANGENE CORPORA... Filed on: 04-04-1988 Status: Abandoned-Failure to Resp...	PHARMACEUTICAL PREPARATION, NAMELY, A GENETICALLY ENGINEERED RECOMBINANT EPIDERMAL GROWTH FACTOR TO REGULATE CELL GROWTH	View Details Monitor Mark Create New Watchlist
VERIGEN Owned by: BAXTER INTERNAT... Filed on: 03-07-2000 Status: Abandoned-No Statement of...	RECOMBINANT ANTIHEMOPHILIC FACTOR FOR THE TREATMENT OF HEMOPHILIA	View Details Monitor Mark Create New Watchlist
ABS Owned by: AVENTIS BEHRING... Filed on: 03-06-2000 Status: Abandoned-No Statement of...	Biopharmaceutical preparations for human use containing plasma-derived proteins and recombinant, transgenic, or other synthetic equivalents ther	View Details Monitor Mark Create New Watchlist
VERIDIA Owned by: BAXTER INTERNAT... Filed on: 03-07-2000 Status: Abandoned-After Publicati...	RECOMBINANT ANTIHEMOPHILIC FACTOR FOR THE TREATMENT OF HEMOPHILIA	View Details Monitor Mark Create New Watchlist
SERAGEN Owned by: SERAGEN, INC. Filed on: 11-16-1989 Status: Abandoned-No Statement of...	RECOMBINANT PROTEIN-CONTAINING THERAPEUTIC COMPOSITIONS FOR TREATMENT OF MALIGNANCIES AND AUTOIMMUNE DISEASE ADMINISTERED BY INJECTION BY OR UND	View Details Monitor Mark Create New Watchlist
SERAGEN Owned by: SERAGEN, INC. Filed on: 11-16-1989 Status: Cancelled-Section 8	RECOMBINANT PROTEIN-CONTAINING THERAPEUTIC COMPOSITIONS FOR TREATMENT OF MALIGNANCIES AND AUTOIMMUNE DISEASE ADMINISTERED BY INJECTION BY OR UND	View Details Monitor Mark Create New Watchlist
SERAGEN Owned by: SERAGEN, INC. Filed on: 11-16-1989 Status: Cancelled-Section 8	RECOMBINANT PROTEIN-CONTAINING THERAPEUTIC COMPOSITIONS FOR TREATMENT OF MALIGNANCIES AND AUTOIMMUNE DISEASE ADMINISTERED BY INJECTION BY OR UND	View Details Monitor Mark Create New Watchlist
MERISPASE Owned by: MERISTEM THERAP... Filed on: 01-15-2003 Status: Abandoned-No Statement of...	Pharmaceutical compositions comprising recombinant dog gastric lipase for use in dyspepsia, pancreatic insufficiency, cystic fibrosis/mucoviscid	View Details Monitor Mark Create New Watchlist
LEUCAN Owned by: CANGENE CORPORA... Filed on: 09-18-1987 Status: Abandoned-Failure to Resp...	PHARMACEUTICAL PREPARATIONS, NAMELY, RECOMBINANT LYMPHOKINES USED IN CANCER THERAPY	View Details Monitor Mark Create New Watchlist
MATRHELLIS Owned by: LABORATOIRE FRA... Filed on: 09-18-2009 Status: N/A	Pharmaceutical preparations in the nature of monoclonal recombinant anti-rhesus D antibodies for the prevention of RhD alloimmunization in RhD-n	View Details Monitor Mark Create New Watchlist
VASGENE Owned by: VASGENE THERAPE... Filed on: 05-20-2002 Status: Cancelled-Section 8	DIAGNOSTIC RECOMBINANT VECTORS FOR CLONING, MANIPULATING AND EXPRESSING RECOMBINANT DNA FOR SCIENTIFIC AND MEDICAL RESEARCH USE; DIAGNOSTIC CHEM	View Details Monitor Mark Create New Watchlist

Preparing summary view, please wait...

Owner Summary

This report includes a summary of your search results. The 'Marks Matched' column indicates the number of results that match a particular trademark owner, It does not include all of their other marks.

Primary Classification Summary

Status Summary

File Year Summary

Registration Statistics

Quick Links

Updated Daily